Table 1. Baseline characteristics of the 1,415 PLHIV aged 60 years or more from the Dat’AIDS cohort.
| Baseline characteristics (N = 1415) |
||
|---|---|---|
| Male sex [n (%)] | 1093 | (77.2) |
| Age (years) [mean (±SD)] | 65.7 | (±5.5) |
| 60–64 years [n (%)] | 754 | (53.3) |
| 65–74 years [n (%)] | 544 | (38.5) |
| 75 years or more [n (%)] | 117 | (8.3) |
| Mode of HIV infection [n (%)] | ||
| Heterosexual | 630 | (44.5) |
| Homosexual | 556 | (39.3) |
| Injecting drug user | 9 | (0.6) |
| Other | 220 | (15.6) |
| Duration of known HIV infection (years) [mean (±SD)] | 11.9 | (±6.1) |
| ART-experienced [n (%)] | 1248 | (88.2) |
| Duration of ART treatment (years) [mean (±SD)] (n = 1248) | 9.6 | (±4.8) |
| AIDS [n (%)] | 426 | (30.1) |
| Age-related comorbidities [n (%)] | ||
| Cancer | 229 | (16.2) |
| Non HIV-related cancer | 94 | (6.6) |
| Cardiovascular diseases | 172 | (12.2) |
| Cerebrovascular disease | 77 | (5.4) |
| Myocardial infarction | 67 | (4.7) |
| Congestive heart failure | 42 | (3.0) |
| Chronic pulmonary disease | 112 | (7.9) |
| Decreased eGFR | 285 | (20.1) |
| Diabetes | 201 | (14.2) |
| Cirrhosis | 39 | (2.8) |
| HBV co-infection | 54 | (3.8) |
| HCV co-infection | 92 | (6.5) |
| Low body mass index (<18.5 kg/m2) (missing = 29) [n (%)] | 76 | (5.5) |
| CD4 cell count (cells/μl) [mean (±SD)] | 507 | (±245) |
| >500 cells/μl | 653 | (46.2) |
| 350–500 cells/μl | 364 | (25.7) |
| 200–349 cells/μl | 299 | (21.1) |
| <200 cells/μl | 99 | (7.0) |
| CD4 nadir (cells/μl) [mean (±SD)] | 210 | (±174) |
| ≥200 cells/μl [n(%)] | 619 | (43.8) |
| <200 cells/μl [n(%)] | 796 | (56.2) |
| HIV Viral Load >50 copies/ml [n (%)] (missing = 3) | 331 | (23.4) |
| Estimated glomerular filtration rate (CKD-EPI) (missing = 28) | ||
| ≥60 ml/mn/1.73m2 [n(%)] | 1095 | (78.9) |
| 30–59 ml/mn/1.73m2 [n(%)] | 266 | (19.2) |
| <30 ml/mn/1.73m2 [n(%)] | 26 | (1.9) |
| Anemia* (missing = 33) | 296 | (21.4) |
PLHIV, people living with HIV; HIV, human immunodeficiency virus; AIDS, acquired immune deficiency syndrome; ART, antiretroviral treatment; HBV, hepatitis B virus; HCV, hepatitis C virus; eGFR, estimated glomerular filtration rate; SD, standard deviation
*Anemia was defined as a hemoglobin level <12g/dL for women, and <13g/dL for men